| 英文别名 |
Benzenesulfonamide,4-[5-(2,4-difluorophenyl)-4,5-dihydro-3-(trifluoromethyl)-1H-pyrazol-1-yl]-;Enflicoxib;HY-19384;4-(5-(2,4-difluorophenyl)-4,5-dihydro-3-trifluoromethyl-1h-pyrazol-1-yl)benzenesulfonamide;CHEMBL5315060;4-(3-(2,4-Difluorophenyl)-5-(trifluoromethyl)-3,4-dihydropyrazol-2-yl)benzenesulfonamide;Enflicoxib [INN];AKOS040748300;Benzenesulfonamide, 4-(5-(2,4-difluorophenyl)-4,5-dihydro-3-(trifluoromethyl)-1H-pyrazol-1-yl)-;E-6087;DA-73108;1-(4-aminosulphonylphenyl)-5-(2,4-difluorophenyl)-4,5-dihydro-3-trifluoromethyl-1H-pyrazole;4-[3-(2,4-difluorophenyl)-5-(trifluoromethyl)-3,4-dihydropyrazol-2-yl]benzenesulfonamide;SCHEMBL26427;4-(5-(2,4-difluorophenyl)-3-(trifluoromethyl)-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide;MS-26929;251442-94-1;1-(4-Aminosulfonylphenyl)-5-(2,4-difluorophenyl)-4,5-dihydro-3-trifluoromethyl-1H-pyrazole;UNII-VM9PYQ1MQG;E-6087, (+/-)-;VM9PYQ1MQG;CS-0015483;Daxocox |